← Leaderboards
Vahid Yaghmai
Northwestern University At Chicago
$1,487,571
Attributed
$2,975,141
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $753.8K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,975,141 · 2
By mechanism
R01$2,975,141 · 2
Top collaborators
- Zhuoli Zhang8 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Dong-Hyun Kim$8,303,552
- Zhuoli Zhang$4,626,286
- Zeeshan Ahmad Butt$965,544
Others in their field
Other Emerging Leaders on “Measurement”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Yunda Huang · Fred Hutchinson Cancer Center$53,797,542
- Susan M Landau · University Of California Berkeley$47,252,026
- John Hobbs · Suny At Stony Brook$41,857,417
- Christopher Bee · Suny At Stony Brook$41,239,084
Research focus
MeasurementNeoplastic CellImmunotherapyMagnetismExcisionNanocomplexesFerumoxytolHomingIn VivoMagnetic Resonance ImagingEarly Detection BiomarkersCancer EtiologyMigrationMonitorClinical ApplicationCancer TherapyBiodistributionHeparinIndividual PatientCurative TreatmentsLabelLiver NeoplasmsDoseOperative Surgical Procedures
Grant awards (8)
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis$392,500
R01 · FY2025 · CA
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis$372,875
R01 · FY2024 · CA
Image-guided Interventional Combination Liver Cancer Immunotherapy$350,267
R01 · FY2024 · CA
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis$392,500
R01 · FY2023 · CA
Image-guided Interventional Combination Liver Cancer Immunotherapy$361,328
R01 · FY2023 · CA
Image-guided Interventional Combination Liver Cancer Immunotherapy$361,348
R01 · FY2022 · CA
Image-guided Interventional Combination Liver Cancer Immunotherapy$368,722
R01 · FY2021 · CA
Image-guided Interventional Combination Liver Cancer Immunotherapy$375,601
R01 · FY2020 · CA